Cytochrome P450s and uses thereof
AssigneeBoard of Trustees of the University of Kentucky
InventorsJoseph Chappell, Lyle F. Ralston
Life of this patent
Estimating the term…
Abstract
The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
Claims6
A method for producing an isoprenoid compound, said method comprising the steps of:
- culturing a host cell under conditions suitable for expressing a first recombinant protein comprising an isoprenoid synthase and a second recombinant protein comprising a CYP71 family cytochrome P450 polypeptide, wherein said first and second recombinant protein catalyze the formation of an isoprenoid compound not normally produced by said host cell;
- and
- recovering said isoprenoid compound, wherein said cytochrome P450 polypeptide is selected from the group consisting of a polypeptide comprising at least 95% identity to the amino acid sequence of SEQ ID NO:1, and a polypeptide comprising at least 95% identity to the amino acid sequence of SEQ ID NO:3.
A method for producing an altered isoprenoid compound, said method comprising the step of contacting an isoprenoid compound with an isolated CYP71 family cytoebrome P450 polypeptide, wherein said polypeptide catalyzes the formation of an isoprenoid compound, under conditions allowing for the hydroxylation, oxidation, demethylation, methylation, or any combination thereof of said compound and recovering said altered isoprenoid compound, wherein the isolated CYP71 family cytochrome P450 polypeptide comprises an amino acid sequence at least 95% identical to the amino acid sequence of SEQ ID NO:
- 1 or of SEQ ID NO:
- 3.
A method for producing an altered isoprenoid compound, said method comprising the step of contacting an isoprenoid compound with an isolated CYP71 family cytochrome P450 polypeptide, wherein said polypeptide catalyzes the formation of an isoprenoid compound, under conditions allowing for the hydroxylation, oxidation, demethylation, methylation, or any combination thereof of said compound and recovering said altered isoprenoid compound, wherein the isolated CYP71 family cytochrome P450 polypeptide comprises an amino acid sequence that is encoded by a nucleic acid sequence at least 95% identical to the nucleic acid sequence of SEQ ID NO:
- 2 or of SEQ ID NO:
- 4.
A host cell expressing a recombinant isoprenoid synthase and a recombinant CYP71 family cytochrome P450 polypeptide, wherein said second recombinant protein has hydroxylase activity, and further wherein said first and second recombinant protein catalyze the formation of an isoprenoid compound not normally produced by said host cell, wherein the recombinant CYP71 family cytochrome P450 polypeptide comprises an amino acid sequence at least 95% identical to the amino acid sequence of SEQ ID NO:
- 1 or of SEQ ID NO:
- 3.
A host cell expressing a recombinant isoprenoid synthase and a recombinant CYP71 family cytochrome P450 polypeptide, wherein said second recombinant protein has hydroxylase activity, and further wherein said first and second recombinant protein catalyze the formation of an isoprenoid compound not normally produced by said host cell, wherein the recombinant CYP71 family cytochrome P450 polypeptide comprises an amino acid sequence that is encoded by a nucleic acid sequence at least 95% identical to the nucleic acid sequence of SEQ ID NO:
- 2 or of SEQ ID NO:
- 4.
A method for producing an isoprenoid compound, said method comprising the steps of:
- culturing a host cell under conditions suitable for expressing a first recombinant protein comprising an isoprenoid synthase and a second recombinant protein comprising a CYP71 family cytochrome P450 polypeptide, wherein said second recombinant protein has hydroxylase activity, and further wherein said first and second recombinant protein catalyze the formation of an isoprenoid compound not normally produced by said host cell;
- and
- recovering said isoprenoid compound, wherein the cytochrome P450 comprises an amino acid sequence that is encoded by a nucleic acid sequence at least 95% identical to the nucleic acid sequence of SEQ ID NO:
- 2 or of SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.